BioCardia, Inc. (BCDA) › Capital ExpendituresBioCardia, Inc. (BCDA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $1.07M2011: $137.0K2012: $02015: $125.0K2017: $136.0K2018: $66.0K2019: $146.0K2020: $32.0K2021: $116.0K2022: $70.0K2023: $12.0K2024: $6.0K2025: $7.0K$7.0K2010Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$7.0K+16.7%2024$6.0K-50.0%2023$12.0K-82.9%2022$70.0K-39.7%2021$116.0K+262.5%2020$32.0K-78.1%2019$146.0K+121.2%2018$66.0K-51.5%2017$136.0K—2015$125.0K—2012$0-100.0%2011$137.0K-87.2%2010$1.07M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share